Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-20 Sale |
2025-03-21 5:31 pm |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
40,000 | $5.4311 | $217,244 | 1,353,510 (Direct) |
View |
2021-10-05 Sale |
2021-10-05 5:34 pm |
XERIS PHARMACEUTICALS INC | XERS | Hecht Beth See Remarks |
206,366 | $0 | $0 | 0 (Direct) |
View |
2021-03-19 Sale |
2021-03-19 5:34 pm |
Neos Therapeutics Inc. | NEOS | Hecht Beth Director |
23,453 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-31 Option Award |
2025-02-03 7:39 pm |
N/A 2027-03-02 |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
485,000 | $0 | 1,693,510 (Direct) |
View |
2025-01-31 Tax Withholding |
2025-02-03 7:39 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
144,284 | $3.56 | 1,693,510 (Direct) |
View |
2025-01-03 Tax Withholding |
2025-01-07 4:40 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
32,039 | $3.61 | 1,352,794 (Direct) |
View |
2024-01-29 Tax Withholding |
2024-08-09 4:07 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
19,675 | $2.66 | 1,380,802 (Direct) |
View |
2022-01-29 Tax Withholding |
2024-08-09 4:07 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
18,485 | $2.11 | 1,380,802 (Direct) |
View |
2024-01-03 Tax Withholding |
2024-08-09 4:07 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
33,488 | $2.24 | 1,380,802 (Direct) |
View |
2023-01-29 Tax Withholding |
2024-08-09 4:07 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
21,177 | $1.26 | 1,380,802 (Direct) |
View |
2023-01-31 Tax Withholding |
2024-08-09 4:07 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
5,784 | $1.24 | 1,380,802 (Direct) |
View |
2023-01-03 Tax Withholding |
2024-08-09 4:07 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
33,488 | $1.12 | 1,380,802 (Direct) |
View |
2024-01-31 Tax Withholding |
2024-08-09 4:07 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
45,909 | $2.46 | 1,380,802 (Direct) |
View |
2024-01-31 Option Award |
2024-01-31 5:04 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
750,000 | $0 | 1,554,968 (Direct) |
View |
2023-06-15 Exercise |
2023-06-15 5:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Hecht Beth Director |
15,853 | $0 | 18,839 (Direct) |
View |
2023-01-31 Option Award |
2023-02-01 4:12 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
350,000 | $0 | 797,758 (Direct) |
View |
2022-06-23 Exercise |
2022-06-24 6:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Hecht Beth Director |
36,798 | $0 | 44,805 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 5:02 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Hecht Beth Director |
237,795 | $0.01 | 237,795 (Direct) |
View |
2022-03-18 Exercise |
2022-03-22 7:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Hecht Beth Director |
7,642 | $0 | 8,007 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 6:16 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
225,000 | $0 | 436,821 (Direct) |
View |
2021-10-05 Option Award |
2021-10-05 7:37 pm |
N/A 2028-01-30 |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
488,866 | $0 | 488,866 (Direct) |
View |
2021-06-23 Option Award |
2021-06-25 4:05 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Hecht Beth Director |
36,798 | $0 | 36,798 (Direct) |
View |
2021-04-08 Option Award |
2021-04-12 3:22 pm |
N/A N/A |
AYTU BIOPHARMA INC | AYTU | Hecht Beth Director |
6,500 | $0 | 9,052 (Direct) |
View |
Ownership |
2021-03-26 09:30 am |
N/A N/A |
AYTU BIOPHARMA INC | AYTU | Hecht Beth Director |
0 | $0 | 2,552 (Direct) |
View |
2021-03-18 Option Award |
2021-03-19 4:30 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Hecht Beth Director |
7,642 | $0 | 7,642 (Direct) |
View |
2021-01-29 Option Award |
2021-02-01 4:11 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Hecht Beth See Remarks |
150,000 | $0 | 210,814 (Direct) |
View |
2020-08-14 Option Award |
2020-08-17 4:25 pm |
N/A 2030-08-14 |
XERIS PHARMACEUTICALS INC | XERS | Hecht Beth See Remarks |
150,000 | $0 | 210,814 (Direct) |
View |
2020-06-30 Option Award |
2020-07-15 4:54 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Hecht Beth See Remarks |
3,731 | $2.26 | 60,814 (Direct) |
View |
2020-06-10 Option Award |
2020-06-11 8:22 pm |
N/A N/A |
Neos Therapeutics Inc. | NEOS | Hecht Beth Director |
23,453 | $0 | 23,453 (Direct) |
View |